<DOC>
	<DOC>NCT00999908</DOC>
	<brief_summary>This study compared the effects of a single dose of indacaterol with that of a single dose of tiotropium on inspiratory capacity.</brief_summary>
	<brief_title>Comparison of the Effects of Indacaterol and Tiotropium on Inspiratory Capacity</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases, Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
	<mesh_term>Tiotropium Bromide</mesh_term>
	<criteria>Diagnosis of moderate (as classified by the Global Initiative for Chronic Obstructive Lung Disease [GOLD] Guidelines, 2007) chronic obstructive pulmonary disease (COPD) and: 1. Smoking history of at least 10 packyears. 2. Forced expiratory volume in 1 second (FEV1) &lt; 80% and â‰¥ 50% of the predicted normal value. 3. Postbronchodilator FEV1/Force vital capacity (FVC) &lt; 0.7. Patients who have had a COPD exacerbation requiring systemic glucocorticosteroid treatment or antibiotics and/or hospitalization in the 6 weeks prior to screening. Patients who have had a respiratory tract infection within 6 weeks prior to screening. Patients with concomitant pulmonary disease. Patients with alpha1antitrypsin deficiency. Patients with contraindications for tiotropium treatment. Patients with a history of hypersensitivity to any of the study drugs or to drugs from similar drug classes. Other protocoldefined inclusion/exclusion criteria applied to the study.</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>COPD</keyword>
	<keyword>indacaterol</keyword>
	<keyword>tiotropium</keyword>
</DOC>